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Objective: The study objective was to determine whether developments in surgical, anesthetic, and perfusion
techniques in the treatment of type A aortic dissection have resulted in improved clinical outcome.
Methods: A consecutive series of 165 patients undergoing surgical repair of type A aortic dissection performed
between April of 1992 and March of 2006 in a single center were analyzed. Operations were grouped in 2 time
frames of equal length (before April of 1999 vs from April of 1999 onward).
Results: There were 30 in-hospital deaths (18.2%), and the death rate was similar in the 2 time periods. Patients
who underwent operation in the recent era compared with the earlier era were older (median 62 years [interquartile
range 51–68] vs 59 years [45–68], P¼ .18), with a significantly higher incidence of concomitant coronary artery
disease (13 [18%] vs 5 [7%], P ¼ .03]) and significantly worse (moderate to poor) left ventricular function (33
[40%] vs 13 [18%], P¼ .002). The duration of circulatory arrest was shorter in the recent era (median 31 minutes
[interquartile range 26.5–39] vs 37.5 minutes [31–45], P ¼ .009), with a higher incidence of concomitant proce-
dures (19 [21%] vs 10 [14%], P ¼ .22). Except for total hospital stay, which increased over time, there were no
significant differences in postoperative outcome.
Conclusion:Despite the adoption of techniques to improve outcome for patients with type A dissection, mortality
remains unchanged. A deteriorating risk profile and factors relating to the disease process itself may explain this
observation.Acute type A aortic dissection carries a high early mortality
with an exponential decline in survival with time. The inci-
dence of aortic dissection worldwide is estimated to be 0.5 to
2.95 per 100,000 per year.1 Without any intervention it is as-
sociated with a 90%mortality within 2 weeks.2 The hospital
mortality with surgical treatment remains high and in con-
temporary clinical series is between 5% and 25%.2-4
Techniques in this area have evolved, and a number of
groups from major cardiac surgical institutions around the
world have shown that outcomes for surgically treated pa-
tients with type A dissection improved with time.5,6
However, more contemporary series have failed to show
a similar trend.3,7 It is perhaps noteworthy that some of the
best published results have been achieved by the application
of some of the simplest surgical principles in this condition.8,9
Why then might we hypothesize that surgical outcomes
should have improved since the early 1990s? The improved
diagnostic capabilities in local hospitals with around-the-
clock availability of high-quality computed tomography
(CT) scanning has enabled quicker and more accurate diag-
nosis and earlier referral to the specialist center. Because we
know outcome is directly related to the preoperative
state,10,11 this should favor improved results. Isolated re-
placement of the ascending aorta remains the mainstay of
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in perioperative care in both surgery and anesthesia. The de-
velopment of effective surgical glues and pharmacologic
therapies, such as recombinant activated factor VIIa12,13
and aprotinin,14 in concert with thromboelastographically
targeted therapy have reduced bleeding complications. A
greater understanding of the potential for malperfusion has
led to the application of a range of cannulation and perfusion
techniques, most recently with the adjuncts of antegrade ce-
rebral perfusion and axillary artery cannulation.15,16 Newer
anesthetic techniques have included using perioperative
transesophageal echography, monitoring perfusion and aor-
tic valve function, and managing deep hypothermic circula-
tory arrest and pharmacologic adjuncts to neuroprotection.9
There would therefore seem to be ample reason to believe
that the surgical treatment of patients with type A dissection
has improved.
The principal purpose of this observational study was to
assess whether apparent advances in the management of pa-
tients undergoing surgery for type A aortic dissections has
translated into better early and mid-term clinical outcomes.
MATERIALS AND METHODS
Patient Selection
All patients undergoing surgical treatment for type A aortic dissection
during the period from March of 1992 to March of 2006 at the Bristol Heart
Institute were included. To assess and compare the influence of recent
trends, we divided patients into 2 equal time frames: before April 1, 1999
(study period A), and April 1, 1999, onward (study period B).
Data Collection and Definitions
Demographics, preoperative, perioperative, and postoperative data for
procedures before April of 1996 were abstracted from the operation notes.urgery c November 2008
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CT ¼ computed tomography
Because April of 1996 data were collected prospectively on all patients un-
dergoing cardiac surgery and entered into a database (Patient Analysis and
Tracking System (Dendrite Clinical Systems Inc, London, UK), deaths after
hospital discharge were identified from mortality data provided by the Na-
tional Health Service Strategic Tracing Service. All patients were success-
fully matched to the National Health Service Strategic Tracing Service
database.
Arch replacement was defined as operations requiring 2 or more distal
anastomoses, one to the distal aorta and one to 1 or more aortic arch
branches. Thus, if the undersurface of the aortic arch was replaced (hemi-
arch) with a single distal anastomosis, it was considered to be an ascending
aortic operation only. Renal failure for the purpose of our study was defined
as renal impairment requiring hemofiltration. Definitions with respect to the
operative priority, premorbid conditions, and postoperative complications
are those defined by the National Adult Cardiac Surgical Database and ac-
cepted by the Society of Cardiothoracic Surgeons of Great Britain and Ire-
land (available at www.scts.org).
Surgical Techniques
The mainstay of surgical treatment was interposition graft replacement
of the ascending aorta with valve conservation where possible, but com-
posite root replacement was performed for connective tissue disorders or
patients with dilatation or extensive dissection within the sinuses of
Valsalva.
During the study period, a range of approaches and developments oc-
curred continually, often without being adopted at a single time point.
With respect to the surgical techniques in the second time period, more ef-
fective biological glues (Bioglue; Cryolife Europa Ltd, Guildford, UK) re-
placed the Gelatin-resorcin-formalin (GRF), and aggressive resection of the
primary intimal tear with the use of an open distal anastomotic technique has
become routine. The tear in the ascending aorta was replaced to the level of
the innominate artery. Spiral tears extending along the undersurface of the
arch were treated with a beveled distal anastomosis (hemiarch replace-
ments). In time period B, more resections were performed with a hemiarch
replacement. Complete aortic arch replacement was performed only for
tears located within the aortic arch.
From a perfusion perspective, routine femoral artery cannulation
throughout was superseded by the adoption of antegrade reperfusion on
completion of the anastomosis via the side arm of the Ante-Flo (Gelweave;
Vascutek Ltd, Ann Arbor, Mich) graft conduit, and more recently axillary
artery cannulation has been used. Myocardial protection has evolved from
cold crystalloid cardioplegia in the first period to routine use of antegrade
and retrograde cold blood cardioplegia in the second half of the study.
Additional cerebral protection during deep hypothermic circulatory ar-
rest has changed from widespread use of retrograde cerebral perfusion to cir-
culatory arrest alone to the use of antegrade cerebral perfusion via the
axillary artery or endoluminally.
With respect to anesthetic techniques, intraoperative transesophageal
echocardiography has been routine in the second period. Bispectral index,
which is a monitor of anesthetic depth and incorporates time-domain, fre-
quency-domain, and bispectral analysis of the electroencephalograph, was
also used in the second half of the study. Aprotinin was used extensively
throughout the study period, and cell savers were used more commonly lat-
terly. Only toward the end of study period B was recombinant factor VIIa
used to achieve hemostasis in problematic cases. Thromboelastography
has been used exclusively in the latter half (study period B) to guide appro-
priate use of other blood products.The Journal of Thoracic and CStatistical Analysis
Baseline and operative characteristics were compared using the chi-
square or Fisher’s exact test (categoric variables) or the Wilcoxon rank-
sum test (continuous variables).
Because the number of adverse outcomes after surgery was few, the re-
sults were compared without adjustment for baseline and operative charac-
teristics. Binary variables were compared using Fisher’s exact test, and
continuous ‘‘time to event’’ variables were compared using the log-rank
test. Survival curves were calculated using the Kaplan–Meier method. All
analyses were carried out using Stata version 9.2 (Stata Corporation, Col-
lege Station, Tex).
RESULTS
Cohort
A total of 165 eligible patients were identified. Seventy-
four dissections were carried out in the study period A and
91 in study period B. The incidence of referral of type A
aortic dissections has remained fairly constant during the
last 15 years. Eleven surgeons carried out the operations.
The number of procedures ranged from 1 to 61.
Baseline Characteristics
Baseline characteristics were similar across the 2 groups
(Table 1). The only significant difference was in the percent-
age of patients with good, moderate, and poor left ventricu-
lar function; proportionally fewer patients had good function
in the recent era. There were fewer patients with Marfan syn-
drome in the recent era.
In both periods, the cases were predominantly acute aortic
dissections. Only 12 patients (7.2%) in total presented with
an aortic dissection more than 2 weeks old: 3 (4%) in the
early period and 9 (10%) in the more recent era (P ¼ .15).
The incidence of patients presenting with preoperative com-
promise in the 2 eras was also similar (Table 1).
Operative Details
Details of the surgical procedure are summarized in Table
2. Similar numbers of patients had composite root replace-
ments and interposition grafts in the 2 eras, although in the
later period there have been significantly fewer arch replace-
ments. Cardiopulmonary bypass times have increased and
circulatory arrest times have decreased over time. The dura-
tion of the circulatory arrest time was significantly shorter in
the second study period (B).
In-hospital Outcomes
There were 30 in-hospital deaths (18.2%), and the death
rate was similar in the 2 time periods (P ¼ .85, Table 3).
The main causes of early death were cardiac failure, multisys-
tem failure, neurologic causes, bleeding, and gut malperfu-
sion, and the distribution of causes of death in the 2 time
periods was similar (P¼ .99, Table 4). Of the in-hospital out-
comes examined, the reoperation rates for bleeding, inci-
dence of neurologic, and renal complications, and length of
intensive therapy unit stay were similar. The postoperativeardiovascular Surgery c Volume 136, Number 5 1173
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(Study period A) (n ¼ 74) (Study period B) (n ¼ 91)
n % n % P valuea
Age (y) 59 (45–68) 62 (51–68) .18
Male patient 55 74 63 70 .47
Parsonnet score 25 (20–30) 28 (23–32) .16
euroScorea 10 (8–12)
Marfan syndrome 11 15 6 7 .082
Hypertension 41 55 48 54 .85
Peripheral vascular disease 7 9 7 8 .69
LV function Good 61 82 50 60 <.001
Moderate 13 18 35 39
Poor 0 0 5 6
Preoperative angiogram 15 21 9 10 .06
Cardiac arrest 1 1.3 3 3.2 .63
Renal failure 2 2.7 4 4.3 .69
Neurologic event 3 4 2 2.1 .73
Mesenteric ischemia 1 1.3 3 3.2 .63
Limb ischemia 5 6.7 4 4.3 .52
SVC obstruction 1 1.3
SVC, Superior vena cava. aNot recorded in first era.length of hospital stay has increased over time, from a median
of 13 days (interquartile range 10–16 days) for operations be-
fore April of 1999 to a median of 15 days (interquartile range
10–24 days) operation since then (P ¼ .034).
Of the 16 patients who had a permanent stroke, 5 subse-
quently died in the hospital. Four of 26 patients who devel-
oped renal failure died (multisystem failure in 3 and
associated gut malperfusion in 1).
Mid-term Outcome
The median follow-up of survivors who underwent before
April of 1999 (time period A) was 7.9 years. The survival at
3 years, 5 years, and 7 years in this group was 71.5%. 70.1%,
and 61.2%, respectively. However, because the follow-up
was shorter in the later period (time period B), the follow-up1174 The Journal of Thoracic and Cardiovascular Swas censored at 3 years in each group for comparison. There
were 44 deaths in total over the 3 years; 32% occurred within
1 day of surgery. Overall, 3-year survival has not changed
significantly over time (log-rank test, P ¼ .50, Figure 1).
DISCUSSION
In this study we have been unable to demonstrate any im-
provement in early and mid-term clinical outcome for pa-
tients undergoing surgery for type A dissection at the
Bristol Heart Institute during a 15-year period. To our
knowledge, this series represents the largest consecutive in-
stitutional experience from a UK center.
Taken as a whole, these outcomes are in the middle of
contemporary published results.2-4 They do not match the
best results published,8,9 although caution has been advisedTABLE 2. Operative characteristics
(Study period A) (n ¼ 74) (Study period B) (n ¼ 91)
N % N % P valuea
Arch replacement 12 16 4 4 .011
Composite root replacement 21 28 30 33 .53
Interposition graft 49 66 62 68 .79
Without aortic valve replacement 29 59 43 69 .52
With aortic valve replacement 6 13 6 10
Redo procedure 6 8 11 12 .39
Circulatory arrest 59 80% 79 87% .22
Circulatory arrest time (min) 37.5 (31–45) 31 (26.5–39) .0095
Bypass time (min) 149 (118–200) 166 (141–202) .047
Cross clamp time (min) 80 (54–100) 80 (63–111) .30
Mitral valve surgery 1 1 2 2 .58
CABG 9 12 17 19 .25
No. of graftsa 1.2 0.4 1.5 0.6 .20
CABG, Coronary artery bypass graft. aGrafted patients only (mean and standard deviation).urgery c November 2008
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(Study period A) (n ¼ 74) (Study period B) (n ¼ 91)
N % N % P value
Reoperation for bleeding 9 12 11 12 .99
Major sternal wound problems 1 1 1 1 >.99
Neurologic complication 10 14 14 15 .94
Transient 3 4 5 5
Permanent 7 10 9 10
Renal complication 12 16 14 15 .88
In-hospital death 13 18 17 19 .85
ICU stay (d)a 3 (2–7) 4 (2–9) .37
Postoperative hospital stay (d)a 13 (10–16) 15 (10–24) .034
Patient survival 7 d 83.8 73.2–90.5 86.8 77.9–92.3 .50
(95% CI) 30 d 81.0 70.1–88.3 81.3 71.6–88.0
1 y 75.7 64.2–83.9 74.1 63.6–82.0
3 y 75.7 64.2–83.9 69.5 58.3–78.2
ICU, Intensive care unit; CI, confidence interval. aMedian and interquartile range.against believing that limited single surgeon series with
low mortalities provide an accurate reflection of the likely
potential outcome for a patient with type A dissection.17
Studies collecting outcome from large numbers of patients
as registry data probably reflect more accurately potential
outcome. The International Registry of Aortic Dissections3
and the Swedish4 and Taiwanese18 registries report early
mortalities of 25.1%, 22.4%, and 19.6%, respectively, in
type A aortic dissection. The mid-term survival of the pa-
tients in either era of our study period was similar to the
results published by some higher volume centers.2,10
A significant number of studies have analyzed outcome
for type A aortic dissection and typically have identified fac-
tors relating to the patient and the mode of presentation as
the primary determinants of outcome. Patients with previous
cardiac surgery, shock with tamponade, preoperative evi-
dence of stroke, and coronary, visceral, or peripheral malper-
fusion tend to have a worse outcome.2,3,6,9-11 Despite these
considerations, in a single institution, with a considerable
evolution in techniques it is reasonable to expect an im-
provement in outcome.
At the Bristol Heart Institute, the senior surgical personnel
have been relatively constant during this time period. Al-
though the idea of a master surgeon achieving excellence
through undertaking high volumes of such surgery is anThe Journal of Thoracic and Caattractive one, this is an unproven hypothesis and an imprac-
tical proposition. In the area of thoracic aortic surgery, we
have previously presented data suggesting that a group of
surgeons adopting similar techniques can produce equiva-
lent results.19 Given that type A dissection presents as an
emergency and requires prompt intervention, service is
best provided by a group of surgeons with the necessary ex-
pertise, and we favor strongly the approach of Bavaria and
associates8 of an agreed institutional protocol.
At the Bristol Heart Institute, we have identified changes
in several areas in the treatment of these patients during the
15-year period, in terms of the surgical approach, perfusion
and blood conservation techniques, anesthetic neuroprotec-
tive strategies, and routine use of transesophageal echocardi-
ography. Although these changes have been a continuum,
there are major differences between the 2 study periods
1992 to 1999 and 1999 to 2007 in our conduct of this sur-
gery. The observation that major clinical outcomes have
not improved is rather disappointing. Both the Houston5
and Cleveland Clinic6 groups have shown better outcomes
with more recent operation dates. However, both of these
studies cover a much longer time scale than our own. In con-
trast, other authors have indicated that although techniques
have evolved, mortality has not improved in recent years.2
Olsson and associates,4 reporting data from the SwedishTABLE 4. Causes of death
Study period A (No. of deaths ¼ 13) Study period B (No. of deaths ¼ 17)
n % n %
Multisystem failure 3 23 3 18
Cardiac failure 4 31 7 40
Neurologic event 3 23 2 12
Bleeding 2 16 3 18
Visceral malperfusion 1 7 1 6
Other 1 6rdiovascular Surgery c Volume 136, Number 5 1175
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quiring aneurysm resection, whereas those for aortic dissec-
tion have not shown a similar improvement.
Bachet17 recently commented on this issue and concluded
that although we must congratulate our surgical colleagues
who present the best results in observational series, we
must also recognize the likely regression toward the mean
effect of larger series. We must also acknowledge the cata-
strophic nature of the disease, its acute and devastating nat-
ural history, and the end-organ ischemia that results from
cerebral, visceral, or coronary malperfusion. Despite im-
proved surgical expertise, this may continue to remain a chal-
lenge to further improve the outcomes.
In a 15-year experience of 165 consecutive patients with
acute type A dissection treated at a single institution, an
in-hospital mortality of 18.2% was achieved, similar to
that observed in large series reported in the literature. Al-
though we must continue to strive to achieve the best out-
comes, we should not forget the nature and devastating
presentation of type A aortic dissections.
In the future, further development of radiologic tech-
niques, such as the 64-slice CT coronary angiography and
integrated single-photon emission CT and CT coronary an-
giography,20 may provide surgeons anatomic information
about the presence of coronary artery disease. A greater ef-
fort to diagnose coronary artery disease using noninvasive
means may reduce the need for salvage coronary artery by-
pass grafting, which is associated with a significantly higher
mortality, and this is likely to be particularly so in an aging
population.21 Efforts should perhaps also be aimed at pri-
mary prevention of the condition by more aggressive man-
agement of risk factors and by identifying and following
patients at risk of an aortic dissection.
Limitations
There were 2 important limitations of our study. First,
acute aortic dissections at the Bristol Heart Institute are
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FIGURE 1. Kaplan–Meier survival estimates by era.1176 The Journal of Thoracic and Cardiovascular Smanaged by a group of surgeons with a range of clinical ex-
perience and techniques. Although there is a broad consen-
sus over surgical practice, there were individual variations.
For instance, axillary artery cannulation and antegrade cere-
bral perfusion was adopted in 2001 at the Bristol Heart Insti-
tute. However, adoption of this technique was surgeon
dependent and the overall number of patients in whom this
technique was used was low. This may in part explain
why antegrade cerebral perfusion failed to demonstrate
a benefit on neurologic outcomes. A further period of obser-
vation may be necessary because these techniques have now
been more widely disseminated to properly evaluate their
impact on outcome.
The second important limitation relates to the study size.
Increased comorbidity and concomitant procedures in the
more recent era may have counterbalanced any improve-
ment in survival, and perhaps a multivariate analysis would
be of interest. However, only 30 in-hospital deaths in this
series may mean the data are insufficient to allow any mean-
ingful conclusions to be drawn from such an analysis.
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